问题 › 我们的销售周期太长 › Insurance Brokers
销售周期长通常是因为买方未能向CFO建立关于佣金结构和续保保留的内部案例，而不是经纪商未能解释覆盖范围。 保险经纪商面临特定困境——71%的收入来自承运商佣金，而将增量8%转向费用需要替换142个续保账户，并将短期利润率降低1.8至2.3个百分点。在定价之前，19.0将继续因无人能归因的原因而变动，关于阶段持续时间的争论仍将是意见问题。
销售周期长通常是因为买方未能向CFO建立关于佣金结构和续保保留的内部案例，而不是经纪商未能解释覆盖范围。 保险经纪商面临特定困境——71%的收入来自承运商佣金，而将增量8%转向费用需要替换142个续保账户，并将短期利润率降低1.8至2.3个百分点。在定价之前，19.0将继续因无人能归因的原因而变动，关于阶段持续时间的争论仍将是意见问题。
周期长的原因很少是placement的兴趣不足。它停滞在特定点——交易 consistently停留的阶段——通常是经纪商必须向CFO证明决定如何影响71%来自承运商佣金的收入与转向费用的利润影响。
这重新定义了解决方式。缩短周期主要是给champion提供材料，在经纪商不在场的情况下赢得争论：标准佣金与或有佣金的比较、风险控制分析，或显示当前结构为何比什么都不做成本更高的captive可行性数字。
另一个常见原因是卖给无法授权支出的人。这不会延长周期，而是当文件到达控制佣金和费用总收入47.8 million dollars的CFO时，在末端添加一个隐藏周期。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 续保保留数字在同一批账户上季度接季度下滑
✓ 预计或有佣金和标准佣金在同一批机会上低于预期
✓ 失去的placement被无决策取代，而非被竞争经纪商取代
通常会让情况更糟的做法。 增加跟进活动，这加大了champion的压力，却没有提供新材料带给CFO。
It is for you if you run or finance an insurance broker and deals consistently stall at the same stage. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on an insurance broker. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Kesterline Risk Partners, a sample company profile used for testing rather than a customer — 47.8 million dollars in total revenue from commissions and fees.
Excerpt from a real Percision run · Cost Reduction & Efficiency · sample company profile
The move. Convert 460 commission accounts to fee retainers, funding a $3-5M digital workbench from productivity gains while staying inside the $4.8m investment ceiling.
| Investment required | $3.0-5.0M total (base $3.0M, upside $5.0M for accelerated digital workbench) |
| Expected return | 3.2-4.8× over 36 months on $3-5M investment, based on +$4.2-8.5M incremental fee revenue at 35-45% gross margin versus current 19% operating margin. |
| Revenue, year 1 | $50.1-51.8M total revenue (+$2.3-4.0M incremental fee) |
| Revenue, year 2 | $54.4-57.9M total revenue (+$6.6-10.1M incremental fee) |
| Revenue, year 3 | $58.2-64.8M total revenue (+$10.4-17.0M incremental fee) |
| Exit criteria | Strategy should be reversed if, within 12 months, pilot conversion rate falls below 15% OR incremental churn exceeds 5% OR producer productivity drops below $600k average; OR if, within 24 months, cumulative fee revenue does not reach $6.6M incremental run-rate. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Go-to-Market & Commercial Strategy, one of 29 engagements the platform runs. For insurance brokers it works through 19.0, 91.2, 664 and 31, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
找到交易停留最长的阶段，弄清买方在那里必须做什么。这几乎总是内部审批，解决方式是材料而非说服。
这压缩了最后一步，对周期早期的停滞毫无作用，而时间正耗在那里。这还教导买方等待会得到奖励。
不是，如果交易规模和成交率能证明合理。当周期长于现金转换允许的范围时，它才成为问题，这是一个融资约束而非销售约束。
Materially, yes. 71 percent of revenue flows through carrier commissions while shifting an incremental 8 percent to fees would require replacing 142 renewal accounts and cut near-term margin by 1.8 to 2.3 points — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 19.0, 91.2, 664, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 19.0 and 91.2. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית